Ticker
ATAICompany Name
ATAI LIFE SCIENCES NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 0.32 | $ 143.74M | $ 45.28M |
3/31/2025 | 0.29 | $ 152.05M | $ 43.51M |
12/31/2024 | 0.37 | $ 116.3M | $ 42.83M |
9/30/2024 | 0.35 | $ 145.72M | $ 51.2M |
6/30/2024 | 0.28 | $ 167.89M | $ 47.24M |
3/31/2024 | 0.21 | $ 222.54M | $ 45.86M |
12/31/2023 | 0.2 | $ 242.96M | $ 49.16M |
9/30/2023 | 0.15 | $ 266.28M | $ 39.71M |
6/30/2023 | 0.18 | $ 212.55M | $ 37.96M |
3/31/2023 | 0.17 | $ 236.82M | $ 40.08M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Liabilities / Equity
(=) D/E
D/E for ATAI LIFE SCIENCES NV is calculated as follows: Liabilities [ $ 16.18M ] / Equity [ $ 90.82M ]
(=) D/E [ 0.18 ]
Minimum
Jun 30, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.03 |
average | 1.39 |
median | 0.98 |
std | 1.31 |